Poolbeg Pharma PLC (POLB.L) Stock Price
£3.05 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
6 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Poolbeg Pharma PLC, AI stock picks, stock alerts and much more.
POLB.L AI Stock Analysis
AI stock analysis for POLB.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Poolbeg Pharma PLC (POLB.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Poolbeg Pharma PLC (POLB.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Poolbeg Pharma PLC (POLB.L), currently trading at £3.05, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About POLB.L
-
Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom.
-
Symbol
POLB.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
21.3M
Similar Stocks
 |
Codexis 0I0X.L |
$3 5.5% |
5 |
 |
Oxford Nanopore Technologies plc ONT.L |
£208.2 1.3% |
7 |
 |
Sareum Holdings SAR.L |
£22 8.3% |
5 |
 |
Viridian Therapeutics 0K1R.L |
$19.19 8.5% |
6 |
 |
Avacta Group Plc AVCT.L |
£49 1% |
4 |
News
POLB.L Alternative Data
Web Traffic
Poolbeg Pharma PLC receives an estimated 0 monthly visitors to poolbegpharma.com.
-
Web Traffic
0
-
Change from Previous Month
0%
-
3 Month Change
100%
-
YoY Change
100%
Youtube Subscribers
Poolbeg Pharma PLC has 83 subscribers on its main Youtube channel.
-
Youtube Subscribers
83
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
1.2%
Job Postings
Poolbeg Pharma PLC currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Twitter Followers
Poolbeg Pharma PLC has 979 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.8% over the last month.
-
Twitter Followers
979
-
Daily Change
0.2%
-
1 Month Change
0.8%
-
3 Month Change
3.6%
-
YoY Change
3.6%
LinkedIn Employees
According to LinkedIn, Poolbeg Pharma PLC has 15 employees.
-
LinkedIn Employees
15
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Poolbeg Pharma PLC was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Poolbeg Pharma PLC has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
POLB.L Financials
POLB.L Key Metrics
-
Total Revenue
£0
-
Net Income
-£1.1M
-
Earnings per Share
-£2.26
-
Free cash flow
-£1.1K
-
EBITDA
-£1.3K
-
EBITDA Ratio
0
-
Total Assets
£13M
POLB.L 2-year Revenue & Income
POLB.L 2-year Free Cash Flow
POLB.L Technicals
POLB.L SMA
POLB.L RSI
FAQ
What's the current price of Poolbeg Pharma PLC (POLB.L) Stock?
The price of an Poolbeg Pharma PLC (POLB.L) share is £3.05.
What's the market cap of Poolbeg Pharma PLC?
The current market cap of Poolbeg Pharma PLC is 21.3M.
Should I buy or sell POLB.L?
Poolbeg Pharma PLC shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Poolbeg Pharma PLC is better viewed as a hold or accumulate position while waiting for further developments.
Is Poolbeg Pharma PLC a good investment?
The current analysis of Poolbeg Pharma PLC's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Poolbeg Pharma PLC's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Poolbeg Pharma PLC (POLB.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Poolbeg Pharma PLC stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Poolbeg Pharma PLC (POLB.L) that investors often compare it to?
Poolbeg Pharma PLC (POLB.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for Poolbeg Pharma PLC's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Poolbeg Pharma PLC's stock price to be around £3.1 in 2026. Starting from the current price of £3.05, this represents a 1.6% change in price, indicating a neutral outlook for the stock.
How to buy Poolbeg Pharma PLC (POLB.L) Stock?
Poolbeg Pharma PLC stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Poolbeg Pharma PLC shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.